Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Lifespan extension through inhibition of ribonucleotide reductase by resveratrol
FY 2025-26
Summary
As the aging population is projected to grow drastically by 2050, it is becoming increasingly important to combat age-related disorders and the burden of aging on well-being. An interesting compound is resveratrol, which has shown to extend lifespan and protect against conditions related to old age in yeast, flies, and worms. Despite these promising effects, the mechanism through which resveratrol acts is still unclear, limiting progress towards therapeutic applications. Recent genetic studies have shown interest in DNA synthesis pathways, suggesting that replicative stress explains resveratrol’s effects. Specifically, ribonucleotide reductase (RNR), the enzyme that converts ribonucleotides into the deoxynucleotide building blocks of DNA synthesis, has been identified as a molecule that resveratrol may inhibit. While inhibition of murine RNR by resveratrol has been shown, it has not yet been shown with human RNR. Furthermore, current standard tools for measuring RNR activity fall short because they are hazardous, expensive, or are incapable of high-throughput testing. This research will first aim to optimize an assay that uses fluorescence to measure incorporation of RNR-generated deoxyribonucleotides into DNA. Next, this assay will be used to test inhibition of RNR by resveratrol compared to hydroxyurea, a known inhibitor of RNR. Finally, other therapeutics that target aging cells will be tested to determine whether they work similarly through inhibition of RNR. Inhibition by other compounds will be compared to that of resveratrol, and the therapeutic potential of each will be evaluated. Ultimately, this study will help uncover how resveratrol and other therapies prolong lifespan through replicative stress and guide the development of new therapeutics.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573276
Name
Wang Stephanie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Lifespan extension through inhibition of ribonucleotide reductase by resveratrol
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Aging; High-Throughput Assay; Lifespan Extension; Replicative Stress; Resveratrol; Ribonucleotide Reductase
Abstract
As the aging population is projected to grow drastically by 2050, it is becoming increasingly important to combat age-related disorders and the burden of aging on well-being. An interesting compound is resveratrol, which has shown to extend lifespan and protect against conditions related to old age in yeast, flies, and worms. Despite these promising effects, the mechanism through which resveratrol acts is still unclear, limiting progress towards therapeutic applications. Recent genetic studies have shown interest in DNA synthesis pathways, suggesting that replicative stress explains resveratrol’s effects. Specifically, ribonucleotide reductase (RNR), the enzyme that converts ribonucleotides into the deoxynucleotide building blocks of DNA synthesis, has been identified as a molecule that resveratrol may inhibit. While inhibition of murine RNR by resveratrol has been shown, it has not yet been shown with human RNR. Furthermore, current standard tools for measuring RNR activity fall short because they are hazardous, expensive, or are incapable of high-throughput testing. This research will first aim to optimize an assay that uses fluorescence to measure incorporation of RNR-generated deoxyribonucleotides into DNA. Next, this assay will be used to test inhibition of RNR by resveratrol compared to hydroxyurea, a known inhibitor of RNR. Finally, other therapeutics that target aging cells will be tested to determine whether they work similarly through inhibition of RNR. Inhibition by other compounds will be compared to that of resveratrol, and the therapeutic potential of each will be evaluated. Ultimately, this study will help uncover how resveratrol and other therapies prolong lifespan through replicative stress and guide the development of new therapeutics.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wang, Stephanie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~